Check-Cap 'publicly condemned' MediPharm Labs, Chairman Chris Taves
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 04 2025
0mins
Should l Buy ?
Check-Cap's Response to MediPharm Labs: Check-Cap publicly condemned MediPharm Labs and its Chairman, Chris Taves, for spreading false and misleading statements about the company during a sensitive time for Israeli businesses, claiming these actions are unethical and unlawful.
Allegations of Market Manipulation: Check-Cap accuses Mr. Taves of using his position to manipulate their stock price by making baseless accusations regarding their public disclosures, and demands a retraction and apology from both MediPharm Labs and Mr. Taves.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
